U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07228793) titled 'Natural History Study of Patients With EYS-Associated RP' on Nov. 13.
Brief Summary: This natural history study of patients with EYS mutations from Russia and former CIS (Commonwealth of Independent States) territories will accelerate the development of outcome measures for clinical trials. Sensitive, reliable outcome measures of retinal degeneration will greatly facilitate development of treatments for retinitis pigmentosa due to EYS mutations. This approach helps to develop experimental treatment protocol, and assessing its effectiveness.
The goals and expected impact of this natural history study are to:
1. Describe the natural...